Abbott Labarotories is buying CFR Pharmaceuticals of Peru for $2.9 billion announced on Friday afternoon in New York stock exchange
CFR Pharmaceuticals owns 49% of Allergy Therapeutics sharesI wonder if that has anything to do that shares went up on Friday afternoon